Regulation of phosphatidylinositol-5-phosphate signaling by Pin1 determines sensitivity to oxidative stress

Science Signaling

Volumn 5, Issue 252, 2012, Pages

  Keune, Willem Jan ^a   Jones, David R ^a   Bultsma, Yvette ^a   Sommer, Lilly ^a   Zhou, Xiao Zhen ^b   Lu, Kun Ping ^b   Divecha, Nullin ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; INOSITOL PHOSPHATE; PEPTIDYLPROLYL ISOMERASE PIN1; PHOSPHATIDYLINOSITOL 5 PHOSPHATE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL VIABILITY; EMBRYO; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE; FIBROBLAST; GENE EXPRESSION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; EMBRYO, MAMMALIAN; FIBROBLASTS; HEK293 CELLS; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; MICE; MICE, KNOCKOUT; OXIDANTS; OXIDATIVE STRESS; PEPTIDYLPROLYL ISOMERASE; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION;

MUS;

EID: 84870349429     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003223     Document Type: Article

References (80)

1. T. Finkel, N. J. Holbrook, Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247 (2000).
2. A. Musatov, N. C. Robinson, Susceptibility of mitochondrial electron-transport complexes to oxidative damage. Focus on cytochrome c oxidase. Free Radic. Res. 46, 1313-1326 (2012).
3. J. Aguirre, J. D. Lambeth, Nox enzymes from fungus to fly to fish and what they tell us about Nox function in mammals. Free Radic. Biol. Med. 49, 1342-1353 (2010).
4. K. Irani, Y. Xia, J. L. Zweier, S. J. Sollott, C. J. Der, E. R. Fearon, M. Sundaresan, T. Finkel, P. J. Goldschmidt-Clermont, Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275, 1649-1652 (1997).
5. S. Pavlides, I. Vera, R. Gandara, S. Sneddon, R. G. Pestell, I. Mercier, U. E. Martinez-Outschoorn, D. Whitaker-Menezes, A. Howell, F. Sotgia, M. P. Lisanti, Warburg meets autophagy: Cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxid. Redox Signal. 16, 1264-1284 (2012).
6. D. Whitaker-Menezes, U. E. Martinez-Outschoorn, N. Flomenberg, R. C. Birbe, A. K. Witkiewicz, A. Howell, S. Pavlides, A. Tsirigos, A. Ertel, R. G. Pestell, P. Broda, C. Minetti, M. P. Lisanti, F. Sotgia, Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: Visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle 10, 4047-4064 (2011).
7. C. E. Paulsen, K. S. Carroll, Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem. Biol. 5, 47-62 (2010).
8. 3 reveals a nuclear pool that is insensitive to PTEN expression. J. Cell Sci. 119, 5160-5168 (2006).
9. J. Rivera, C. G. Sobey, A. K. Walduck, G. R. Drummond, Nox isoforms in vascular pathophysiology: Insights from transgenic and knockout mouse models. Redox Rep. 15, 50-63 (2010).
10. J. Kisucka, A. K. Chauhan, I. S. Patten, A. Yesilaltay, C. Neumann, R. A. Van Etten, M. Krieger, D. D. Wagner, Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ. Res. 103, 598-605 (2008).
11. T. Shimizu, H. Nojiri, S. Kawakami, S. Uchiyama, T. Shirasawa, Model mice for tissue-specific deletion of the manganese superoxide dismutase gene. Geriatr. Gerontol. Int. 10 (Suppl. 1), S70-S79 (2010).
12. Y. A. Suh, R. S. Arnold, B. Lassegue, J. Shi, X. Xu, D. Sorescu, A. B. Chung, K. K. Griendling, J. D. Lambeth, Cell transformation by the superoxide-generating oxidase Mox1. Nature 401, 79-82 (1999).
13. H. J. McCrea, P. DeCamilli, Mutations in phosphoinositide metabolizing enzymes and human disease. Physiology 24, 8-16 (2009).
14. M. A. Lemmon, Membrane recognition by phospholipid-binding domains. Nat. Rev. Mol. Cell Biol. 9, 99-111 (2008).
15. D. R. Jones, Y. Bultsma, W. J. Keune, J. R. Halstead, D. Elouarrat, S. Mohammed, A. J. Heck, C. S. D'Santos, N. Divecha, Nuclear PtdIns5P as a transducer of stress signaling: An in vivo role for PIP4Kbeta. Mol. Cell 23, 685-695 (2006).
16. D. Sbrissa, O. C. Ikonomov, R. Deeb, A. Shisheva, Phosphatidylinositol 5-phosphate biosynthesis is linked to PIKfyve and is involved in osmotic response pathway in mammalian cells. J. Biol. Chem. 277, 47276-47284 (2002).
17. I. Ndamukong, D. R. Jones, H. Lapko, N. Divecha, Z. Avramova, Phosphatidylinositol 5-phosphate links dehydration stress to the activity of ARABIDOPSIS TRITHORAX-LIKE factor ATX1. PLoS One 5, e13396 (2010).
18. H. J. Meijer, C. P. Berrie, C. Iurisci, N. Divecha, A. Musgrave, T. Munnik, Identification of a new polyphosphoinositide in plants, phosphatidylinositol 5-monophosphate (PtdIns5P), and its accumulation upon osmotic stress. Biochem. J. 360, 491-498 (2001).
19. S. Coronas, F. Lagarrigue, D. Ramel, G. Chicanne, G. Delsol, B. Payrastre, H. Tronchère, Elevated levels of PtdIns5P in NPM-ALK transformed cells: Implication of PIKfyve. Biochem. Biophys. Res. Commun. 372, 351-355 (2008).
20. O. Gozani, P. Karuman, D. R. Jones, D. Ivanov, J. Cha, A. A. Lugovskoy, C. L. Baird, H. Zhu, S. J. Field, S. L. Lessnick, J. Villasenor, B. Mehrotra, J. Chen, V. R. Rao, J. S. Brugge, C. G. Ferguson, B. Payrastre, D. G. Myszka, L. C. Cantley, G. Wagner, N. Divecha, G. D. Prestwich, J. Yuan, The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell 114, 99-111 (2003).
21. D. Sbrissa, O. C. Ikonomov, A. Shisheva, PIKfyve, a mammalian ortholog of yeast Fab1p lipid kinase, synthesizes 5-phosphoinositides. Effect of insulin. J. Biol. Chem. 274, 21589-21597 (1999).
22. +/- mice. J. Biol. Chem. 286, 13404-13413 (2011).
23. D. M. Walker, S. Urbé, S. K. Dove, D. Tenza, G. Raposo, M. J. Clague, Characterization of MTMR3. An inositol lipid 3-phosphatase with novel substrate specificity. Curr. Biol. 11, 1600-1605 (2001).
24. H. Tronchère, J. Laporte, C. Pendaries, C. Chaussade, L. Liaubet, L. Pirola, J. L. Mandel, B. Payrastre, Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. J. Biol. Chem. 279, 7304-7312 (2004).
25. A. Ungewickell, C. Hugge, M. Kisseleva, S. C. Chang, J. Zou, Y. Feng, E. E. Galyov, M. Wilson, P. W. Majerus, The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatases. Proc. Natl. Acad. Sci. U.S.A. 102, 18854-18859 (2005).
26. J. Zou, J. Marjanovic, M. V. Kisseleva, M.Wilson, P. W. Majerus, Type I phosphatidylinositol-4,5-bisphosphate 4-phosphatase regulates stress-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 104, 16834-16839 (2007).
27. L. E. Rameh, K. F. Tolias, B. C. Duckworth, L. C. Cantley, A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. Nature 390, 192-196 (1997).
28. R. Ranganathan, K. P. Lu, T. Hunter, J. P. Noel, Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 89, 875-886 (1997).
29. T. Hsu, D. McRackan, T. S. Vincent, H. Gert de Couet, Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis. Nat. Cell Biol. 3, 538-543 (2001).
30. M. B. Yaffe, M. Schutkowski, M. Shen, X. Z. Zhou, P. T. Stukenberg, J. U. Rahfeld, J. Xu, J. Kuang, M. W. Kirschner, G. Fischer, L. C. Cantley, K. P. Lu, Sequence-specific and phosphorylation-dependent proline isomerization: A potential mitotic regulatory mechanism. Science 278, 1957-1960 (1997).
31. T. H. Lee, L. Pastorino, K. P. Lu, Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert Rev. Mol. Med. 13, e21 (2011).
32. Y. C. Liou, A. Ryo, H. K. Huang, P. J. Lu, R. Bronson, F. Fujimori, T. Uchida, T. Hunter, K. P. Lu, Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. U.S.A. 99, 1335-1340 (2002).
33. A. Ryo, Y. C. Liou, G. Wulf, M. Nakamura, S. W. Lee, K. P. Lu, PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol. 22, 5281-5295 (2002).
34. H. Miyashita, S. Mori, K. Motegi, M. Fukumoto, T. Uchida, Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol. Rep. 10, 455-461 (2003).
35. L. Bao, A. Kimzey, G. Sauter, J. M. Sowadski, K. P. Lu, D. G. Wang, Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 164, 1727-1737 (2004).
36. J. Kuramochi, T. Arai, S. Ikeda, J. Kumagai, H. Uetake, K. Sugihara, High Pin1 expression is associated with tumor progression in colorectal cancer. J. Surg. Oncol. 94, 155-160 (2006).
37. Shc. Science 315, 659-663 (2007).
38. kip1 expression through inhibition of Forkhead box O tumor suppressors. Cancer Res. 68, 7597-7605 (2008).
39. 2 synthesis: Regulation and cellular functions. J. Cell Sci. 122, 3837-3850 (2009).
40. Y. Bultsma, W. J. Keune, N. Divecha, PIP4Kβ interacts with and modulates nuclear localization of the high-activity PtdIns5P-4-kinase isoform PIP4Kα. Biochem. J. 430, 223-235 (2010).
41. J. H. Clarke, J. P. Richardson, K. A. Hinchliffe, R. F. Irvine, Type II PtdInsP kinases: Location, regulation and function. Biochem. Soc. Symp. 74, 149-159 (2007).
42. N. Divecha, O. Truong, J. J. Hsuan, K. A. Hinchliffe, R. F. Irvine, The cloning and sequence of the C isoform of PtdIns4P 5-kinase. Biochem. J. 309, 715-719 (1995).
43. A. M. Castellino, G. J. Parker, I. V. Boronenkov, R. A. Anderson, M. V. Chao, A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4- phosphate 5-kinase. J. Biol. Chem. 272, 5861-5870 (1997).
44. J. H. Clarke, P. C. Emson, R. F. Irvine, Localization of phosphatidylinositol phosphate kinase IIγ in kidney to a membrane trafficking compartment within specialized cells of the nephron. Am. J. Physiol. Renal. Physiol. 295, F1422-F1430 (2008).
45. M. Wang, N. J. Bond, A. J. Letcher, J. P. Richardson, K. S. Lilley, R. F. Irvine, J. H. Clarke, Genomic tagging reveals a random association of endogenous PtdIns5P 4-kinases IIα and IIβ and a partial nuclear localization of the IIα isoform. Biochem. J. 430, 215-221 (2010).
46. Y. Bultsma, W. J. Keune, N. Divecha, PIP4Kβ interacts with and modulates nuclear localization of the high-activity PtdIns5P-4-kinase isoform PIP4Kα. Biochem. J. 430, 223-235 (2010).
47. 1 arrest but not cell replication. Biochem. J. 332 (pt. 1), 43-50 (1998).
48. 2 and PIP5Kα in regulating stress-induced apoptosis. Curr. Biol. 16, 1850-1856 (2006).
49. J. Van der Kaay, M. Beck, A. Gray, C. P. Downes, Distinct phosphatidylinositol 3-kinase lipid products accumulate upon oxidative and osmotic stress and lead to different cellular responses. J. Biol. Chem. 274, 35963-35968 (1999).
50. G. J. Kops, T. B. Dansen, P. E. Polderman, I. Saarloos, K.W.Wirtz, P. J. Coffer, T. T. Huang, J. L. Bos, R. H. Medema, B. M. Burgering, Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316-321 (2002).
51. Z. Tothova, R. Kollipara, B. J. Huntly, B. H. Lee, D. H. Castrillon, D. E. Cullen, E. P. McDowell, S. Lazo-Kallanian, I. R. Williams, C. Sears, S. A. Armstrong, E. Passegue, R. A. DePinho, D. G. Gilliland, FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128, 325-339 (2007).
52. G. M. DeNicola, F. A. Karreth, T. J. Humpton, A. Gopinathan, C. Wei, K. Frese, D. Mangal, K. H. Yu, C. J. Yeo, E. S. Calhoun, F. Scrimieri, J. M. Winter, R. H. Hruban, C. Iacobuzio-Donahue, S. E. Kern, I. A. Blair, D. A. Tuveson, Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106-109 (2011).
53. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J. D. Engel, M. Yamamoto, Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13, 76-86 (1999).
54. S. E. Kim, M. Y. Lee, S. C. Lim, T. T. Hien, J. W. Kim, S. G. Ahn, J. H. Yoon, S. K. Kim, H. S. Choi, K. W. Kang, Role of Pin1 in neointima formation: Down-regulation of Nrf2-dependent heme oxygenase-1 expression by Pin1. Free Radic. Biol. Med. 48, 1644-1653 (2010).
55. T. Nguyen, H. C. Huang, C. B. Pickett, Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J. Biol. Chem. 275, 15466-15473 (2000).
56. K. W. Kang, S. J. Lee, S. G. Kim, Molecular mechanism of Nrf2 activation by oxidative stress. Antioxid. Redox Signal. 7, 1664-1673 (2005).
57. K. W. Kang, S. J. Lee, J. W. Park, S. G. Kim, Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol. Pharmacol. 62, 1001-1010 (2002).
58. A. Brunet, A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, M. E. Greenberg, Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868 (1999).
59. J. Maher, M. Yamamoto, The rise of antioxidant signaling - The evolution and hormetic actions of Nrf2. Toxicol. Appl. Pharmacol. 244, 4-15 (2010).
60. C. M. Clements, R. S. McNally, B. J. Conti, T. W. Mak, J. P. Ting, DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. U.S.A. 103, 15091-15096 (2006).
61. T. P. Williamson, D. A. Johnson, J. A. Johnson, Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity. Neurotoxicology 33, 272-279 (2012).
62. G. P. Sykiotis, D. Bohmann, Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev. Cell 14, 76-85 (2008).
63. L. Romero, K. Andrews, L. Ng, K. O'Rourke, A. Maslen, G. Kirby, Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. Biochem. J. 400, 135-141 (2006).
64. R. Elsby, N. R. Kitteringham, C. E. Goldring, C. A. Lovatt, M. Chamberlain, C. J. Henderson, C. R. Wolf, B. K. Park, Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi. J. Biol. Chem. 278, 22243-22249 (2003).
65. A. T. Dinkova-Kostova, W. D. Holtzclaw, R. N. Cole, K. Itoh, N. Wakabayashi, Y. Katoh, M. Yamamoto, P. Talalay, Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A. 99, 11908-11913 (2002).
66. M. McMahon, K. Itoh, M. Yamamoto, J. D. Hayes, Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278, 21592-21600 (2003).
67. A. Kobayashi, M. I. Kang, H. Okawa, M. Ohtsuji, Y. Zenke, T. Chiba, K. Igarashi, M. Yamamoto, Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24, 7130-7139 (2004).
68. W. Li, M. R. Jain, C. Chen, X. Yue, V. Hebbar, R. Zhou, A. N. Kong, Nrf2 Possesses a redox-insensitive nuclear export signal overlapping with the leucine zipper motif. J. Biol. Chem. 280, 28430-28438 (2005).
69. M. Velichkova, T. Hasson, Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism. Mol. Cell. Biol. 25, 4501-4513 (2005).
70. L. M. Zipper, R. T. Mulcahy, Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells. Toxicol. Sci. 73, 124-134 (2003).
71. Cip1/WAF1 upregulates the Nrf2-mediated antioxidant response. Mol. Cell 34, 663-673 (2009).
72. C. Xu, X. Yuan, Z. Pan, G. Shen, J. H. Kim, S. Yu, T. O. Khor, W. Li, J. Ma, A. N. Kong, Mechanism of action of isothiocyanates: The induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol. Cancer Ther. 5, 1918-1926 (2006).
73. P. Stopkova, T. Saito, C. S. Fann, D. F. Papolos, J. Vevera, I. Paclt, I. Zukov, R. Stryjer, R. D. Strous, H. M. Lachman, Polymorphism screening of PIP5K2A: A candidate gene for chromosome 10p-linked psychiatric disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 123B, 50-58 (2003).
74. P. Stopkova, J. Vevera, I. Paclt, I. Zukov, D. F. Papolos, T. Saito, H. M. Lachman, Screening of PIP5K2A promoter region for mutations in bipolar disorder and schizophrenia. Psychiatr. Genet. 15, 223-227 (2005).
75. S. C. Bakker, M. L. Hoogendoorn, J. Hendriks, K. Verzijlbergen, S. Caron, W. Verduijn, J. P. Selten, P. L. Pearson, R. S. Kahn, R. J. Sinke, The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav. 6, 113-119 (2007).
76. O. Fedorenko, N. Strutz-Seebohm, U. Henrion, O. N. Ureche, F. Lang, G. Seebohm, U. E. Lang, A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels. Psychopharmacology 199, 47-54 (2008).
77. O. Fedorenko, C. Tang, M. Sopjani, M. Föller, E. M. Gehring, N. Strutz-Seebohm, O. N. Ureche, S. Ivanova, A. Semke, F. Lang, G. Seebohm, U. E. Lang, PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3. Psychopharmacology 206, 429-435 (2009).
78. J. Laporte, F. Bedez, A. Bolino, J. L. Mandel, Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum. Mol. Genet. 12 (suppl. 2), R285-R292 (2003).
79. 2-mediated signalling in human disease. Trends Pharmacol. Sci. 26, 654-660 (2005).
80. C. Gewinner, Z. C. Wang, A. Richardson, J. Teruya-Feldstein, D. Etemadmoghadam, D. Bowtell, J. Barretina, W. M. Lin, L. Rameh, L. Salmena, P. P. Pandolfi, L. C. Cantley, Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Cancer Cell 16, 115-125 (2009).